Figure 8

SKCM was the most beneficial cancer for targeting hub genes. (a) DSS survival curves comparison of high and low expression of HF hub genes in SKCM. (b) HF hub genes were correlated with CD8+T-cells in SKCM.
SKCM was the most beneficial cancer for targeting hub genes. (a) DSS survival curves comparison of high and low expression of HF hub genes in SKCM. (b) HF hub genes were correlated with CD8+T-cells in SKCM.